Nano vesicular approaches for the treatment of skin cancer.

IF 5.2 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Shweta Singh, Ankur Vaidya, Navneet Verma
{"title":"Nano vesicular approaches for the treatment of skin cancer.","authors":"Shweta Singh, Ankur Vaidya, Navneet Verma","doi":"10.1016/j.ijpharm.2025.126265","DOIUrl":null,"url":null,"abstract":"<p><p>Skin cancer is increasing as a global health issue, with rising cases particularly in Caucasian populations. It is the most common cause of decreased quality of life worldwide. There are an estimated 1.5 million new cases each year. The conventional chemotherapy treatment is challenging and often ineffective. These problems can be overcome by the use of lipid nanoparticles and may allow for early detection and monitoring of neoplastic changes, and determine the effectiveness of the treatment. The lipid nanoparticle is significant in delivery systems due to its non-invasive and targeted delivery system is based on the type of active drug. Due to its ability to penetrate deep into the layers of the skin, skin delivery systems are capable of delivering drugs to target cells in a protected manner. Research over the previous decade on carriers of active substances indicates that drugs can be delivered more accurately to the tumor site, resulting in higher therapeutic efficacy. This article describes the application of liposomes, niosomes, ethosomes, transethosomes, transferosomes, invasomes, metal nanoparticles, and polymer nanoparticles in existing therapies. This review aimed to examine the properties and applications of nano lipid carriers used in the treatment and prevention of numerous types of skin cancer.</p>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":" ","pages":"126265"},"PeriodicalIF":5.2000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijpharm.2025.126265","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Skin cancer is increasing as a global health issue, with rising cases particularly in Caucasian populations. It is the most common cause of decreased quality of life worldwide. There are an estimated 1.5 million new cases each year. The conventional chemotherapy treatment is challenging and often ineffective. These problems can be overcome by the use of lipid nanoparticles and may allow for early detection and monitoring of neoplastic changes, and determine the effectiveness of the treatment. The lipid nanoparticle is significant in delivery systems due to its non-invasive and targeted delivery system is based on the type of active drug. Due to its ability to penetrate deep into the layers of the skin, skin delivery systems are capable of delivering drugs to target cells in a protected manner. Research over the previous decade on carriers of active substances indicates that drugs can be delivered more accurately to the tumor site, resulting in higher therapeutic efficacy. This article describes the application of liposomes, niosomes, ethosomes, transethosomes, transferosomes, invasomes, metal nanoparticles, and polymer nanoparticles in existing therapies. This review aimed to examine the properties and applications of nano lipid carriers used in the treatment and prevention of numerous types of skin cancer.

纳米囊泡法治疗皮肤癌。
皮肤癌作为一个全球性的健康问题正在增加,尤其是在高加索人群中。它是世界范围内生活质量下降的最常见原因。据估计,每年有150万新病例。传统的化疗具有挑战性,而且往往无效。这些问题可以通过使用脂质纳米颗粒来克服,并且可能允许早期发现和监测肿瘤变化,并确定治疗的有效性。脂质纳米颗粒在给药系统中具有重要意义,因为它的非侵入性和靶向给药系统是基于活性药物的类型。由于其能够深入皮肤层,皮肤输送系统能够以受保护的方式将药物输送到目标细胞。过去十年对活性物质载体的研究表明,药物可以更准确地递送到肿瘤部位,从而获得更高的治疗效果。本文介绍了脂质体、脂质体、脂质体、转运体、转移体、侵入体、金属纳米颗粒和聚合物纳米颗粒在现有治疗中的应用。本文综述了纳米脂质载体的性质及其在多种类型皮肤癌的治疗和预防中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.70
自引率
8.60%
发文量
951
审稿时长
72 days
期刊介绍: The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信